kidney; Na ϩ -K ϩ -ATPase; phospholipase C; dopamine RENAL DOPAMINE PLAYS A KEY ROLE for the regulation of sodium metabolism. There are principally two types of dopamine receptors, which from the beginning were characterized with regard to their capacity to activate (D 1 ) or inhibit (D 2 ) the activity of adenylate cyclase (9, 13) . More recent evidence suggests that dopamine receptors can also signal via other pathways. Thus there are a number of observations from studies on renal tissue indicating that dopamine receptors can couple to phospholipase C (PLC) (22, 23) and that the physiological effects of dopamine are abolished in the presence of specific protein kinase C (PKC) inhibitors (3, 7, 17) .
Direct evidence that dopamine activates PKC is, however, still lacking. Several PKC isoforms have been identified. On the basis of their different activators they have been subdivided into three families, which are designated as classic, novel, and atypical PKC. Activation of PKC is generally associated with a translocation of the enzyme to the plasma membrane or to specific binding sites within the cell (14) (15) (16) . The advent of confocal microscopy has greatly improved the possibilities to visualize cellular processes that involve transport of proteins. In the present study, performed on a proximal tubule-like cell line, we used this technique to examine the effect of dopamine, and the role of its receptors, on the localization of PKC isoforms from the three families.
METHODS
Cells. LLCPK-1 is a renal epithelial cell line, which has several characteristics of proximal tubular cells. Cells were grown to confluence for 4-5 days in 10-cm dishes at 37°C in a humidified atmosphere with 5% CO 2 in Dulbecco's modified Eagle's medium (DMEM; pH 7.6) supplemented with 10% fetal bovine serum (FBS), penicillin (100 mg/ml), and streptomycin (100 mg/ml).
Immunofluorescence. Cells were harvested by trypsinization, replated on 12-mm coverslips coated with fibronectin, and incubated for 1 h at 37°C in a humidified atmosphere with 5% CO 2 in modified phosphate-buffered saline (mPBS; pH 7.4; in mM: 137 NaCl, 2.7 KCl, 80 Na 2 HPO 4 , 21 NaH 2 PO 4 , 2.4 CaCl 2 , and 0.4 MgSO 4 ) supplemented with 0.1% bovine serum albumin (mPBS-BSA). Coverslips with adherent cells were washed once in mPBS-BSA, incubated with drug or vehicle for the desired time, and fixed for 20 min in ice-cold 2% paraformaldehyde. Cells were washed with mPBS, blocked, and permeabilized in mPBS with 7% normal goat serum (NGS), 5% nonfat dry milk (NFDM), and 0.1% saponin for 10 min at 37°C. The cells were incubated overnight at 4°C in mPBS containing 1.4% NGS, 1% NFDM, 0.1% saponin, and affinity-purified polyclonal antibodies directed against peptide sequences of PKC that reacted specifically with the ␣-, ␦-, ␥-, ⑀-, and -isoforms of PKC. After being washed with mPBS containing 0.1% saponin, the cells were incubated for 1 h at room temperature with secondary goat anti-rabbit Texas Red X antibody. The cells were washed again and mounted in Prolong antifade. Each experiment was repeated at least three times. Negative controls included cells incubated with primary antibodies preabsorbed with their respective immunizing peptides and cells incubated with secondary antibodies alone.
The viability of the cells after incubation with drug or vehicle was checked with the trypan blue extrusion method. For this purpose LLCPK-1 cells were incubated at 37°C in a humidified atmosphere with 5% CO 2 with mPBS-BSA or with M199 medium plus 0.1% BSA. After 1 h of incubation, viability was evaluated by trypan blue extrusion. There was no difference in the ratio of unstained to stained cells between cells incubated with mPBS-BSA or M199 medium plus BSA.
Confocal microscopy. Confocal microscopy recordings were done with the use of a Zeiss LSM410 inverted confocal scanning laser microscope with excitation at 543 nm and longpass detection at 570 nm. Optical sections through the center of the cells were used for localization of the immunofluorescent signal. Between 50 and 100 cells from each coverslip were analyzed. From those, five representative cells were recorded.
Immunoblotting studies. Cell monolayers were washed twice with prewarmed (37°C) mPBS (pH 7.4) and incubated for 10 min at room temperature with mPBS in the absence or presence of dopamine (final concentration 10 Ϫ5 M) or phorbol 12,13-dibutyrate (PDBu; final concentration 10 Ϫ6 M). Incubation was stopped by aspiration of the medium. The cell monolayer was covered with 2 ml of ice-cold homogenization buffer (20 mM Tris ⅐ HCl, containing a protease inhibitor cocktail tablet, final concentration in g/ml: 60 antipain dihydrochloride, 10 bestatin, 20 chymostatin, 60 E-64, 10 leupeptin, 10 pepstatin, 60 phosphoramidon, 400 pefabloc SC, 200 EDTA disodium salt, 10 aprotinin, pH 7.4). Cells were disrupted by three cycles of freezing (dry ice, 5 min) and thawing (37°C water bath, 5 min). To obtain cell cytosol and membrane fractions, we centrifuged the lysate at 28,000 rpm (4°C, 60 min). After protein measurements were obtained, the supernatant containing the cytosolic fraction was diluted in loading buffer (1% SDS, 0.25 mM Tris ⅐ HCl, 10% glycerol, 5% ␤-mercaptoethanol), boiled for 3 min, and stored at Ϫ70°C. The pellet was resuspended in homogenization buffer plus 1% (vol/vol) Triton X-100, incubated at room temperature for 30 min, and centrifuged at 28,000 rpm (4°C, 60 min). The supernatant containing the membrane fraction was treated in the same way as that containing the cytosol extracts. Immediately after centrifugation, an aliquot of the cytosolic or membrane fraction dissolved in homogenization buffer or homogenization buffer plus 1% (vol/vol) Triton X-100, respectively, was used for the measurement of protein concentration. In both fractions protein concentration was determined according to Bradford (4) . Cytosolic and membrane samples (stored in loading buffer), containing equal amounts of protein (10 g), were separated by electrophoresis on SDS-polyacrylamide gels (8% acrylamide in the running gel), transferred to a polyvinylidene difluoride (PVDF) membrane, and probed with PKC isoenzyme-specific antibodies. After being washed, membranes were incubated with peroxidase-conjugated anti-rabbit polyclonal antibodies and examined with an enhanced chemiluminescence method (ECL Plus Western blotting analysis system). The control, dopamine, and PDBu samples were always prepared together in a single experiment and run on the same gels. After immunodetection, the PVDF membranes were stained with amido black for 5 min at room temperature and with constant shaking [0.1% (wt/vol) amido black-10B, 10% (vol/vol) methanol, 2% (vol/vol) acetic acid]. The membranes were washed three to four times for 5 min in destaining solution [45% (vol/vol) methanol, 7% (vol/vol) acetic acid] as a control for protein loading.
The X-ray films were scanned using an HP ScanJet 5100C and HP PrecisionScan software (Hewlett-Packard, Palo Alto, CA). The images obtained were analyzed using NIH Image 1.57 software. For each experiment, data were expressed as the ratio of membrane to cytoplasm PKC signal. Values are presented as means Ϯ SE.
Ouabain-sensitive rubidium uptake. Ouabain-sensitive 86 Rb ϩ uptake was used as an index of Na ϩ -K ϩ -ATPase activity. Since the intracellular sodium concentration is substantially lower than that required for half-maximal activation of Na ϩ -K ϩ -ATPase, any changes in intracellular sodium will affect Na ϩ -K ϩ -ATPase activity. To ensure that the recorded effect of dopamine on 86 Rb ϩ uptake was due to a direct effect on Na ϩ -K ϩ -ATPase, measurements were performed in the presence of the sodium ionophore monensin (2 ϫ 10 Ϫ5 M, 20 min). Ouabain-sensitive 86 Rb ϩ uptake was determined in the following groups: 1) control (incubation with PBS only; n ϭ 19), 2) monensin (n ϭ 12), 3) monensin plus the PKC inhibitor Ro-318220 (10 Ϫ7 M, 10 min; n ϭ 7), 4) monensin plus dopamine (10 Ϫ5 M, 3 min; n ϭ 5), and 5) monensin plus Ro-318220 plus dopamine (n ϭ 7). LLCPK-1 cells were washed twice with PBS and incubated at 37°C with the different drugs for the indicated periods. 86 Rb ϩ uptake, which can be used as an index of K ϩ uptake (6), was initiated by addition of 0.1 ml/well PBS containing 25 Ci/ml 86 Rb ϩ . After a 2-min incubation period, the reactions were stopped by aspirating the medium and rinsing the cells three times with 1 ml/well ice-cold PBS containing 5 ϫ 10 Ϫ3 M BaCl 2 . Previous experiments have shown that 86 
Rb
ϩ uptake is linear for at least 5 min. Cells were then lysed twice with 0.55 ml of 1 ϫ 10 Ϫ3 M NaOH. Radioactivity in cell lysates was measured by liquid scintillation counting (LKB Wallac, Sweden). Protein content was determined by the Bradford method (4). Na ϩ -K ϩ -ATPase activity was determined as the difference between 86 Rb ϩ uptake in the absence (total activity) or presence (ouabain-insensitive) of ouabain (10 Ϫ3 M, 40 min) and was expressed as micromoles 86 
ϩ per minute per milligram of protein.
Chemicals. The following drugs were used: dopamine (Giludop, Hannover, Germany), Sch-23390 (Shering-Plough, Bloomfield, NJ), and S-sulpiride (Ravizza, Milan, Italy). Ro-318220 was kindly donated by Roche (London, UK). DMEM, FBS, trypsin, penicillin, and streptomycin were purchased from Life Technologies (Rockville, MD). Polyclonal rabbit antibodies against PKC isoforms and the blocking peptides were from Santa Cruz Biotechnology (Santa Cruz, CA). Goat anti rabbit-Texas Red X antibody and Prolong antifade were purchased from Molecular Probes (Eugene, OR). Protease inhibitor cocktail tablets were from Roche Diagnostics Scandinavia (Bromma, Sweden).
86
Rb ϩ , peroxidase-conjugated anti-rabbit polyclonal antibodies, the ECL Plus Western blotting analysis system, and Hybond-P-PVDF membranes were obtained from Amersham-Pharmacia Biotech (Uppsala, Sweden). All other chemicals of the highest purity available were purchased from Sigma Chemical (St. Louis, MO).
The following drugs were prepared as stock solutions: S-sulpiride was dissolved in methanol, monensin and PDBu were dissolved in ethanol, and U-73122, U-73343, and Ro-318220 were dissolved in DMSO. Further dilutions were performed in the corresponding incubation buffers.
Results
Results from studies of PKC translocation with confocal imaging are shown in Figs. 1-3 . In control LL-CPK-1 cells, PKC-␣, -␥, and -⑀ immunoreactivity signals were randomly located intracellularly, whereas PKC-␦ and -signals were localized in the region of the plasma membrane (Fig. 1) . No signals were observed when the antibodies had been preabsorbed with their corresponding peptides (data not shown). In cells treated with dopamine 10 Ϫ5 M for 3 min, PKC-␣ and -⑀ were translocated to the region of the plasma membrane, whereas the intracellular localization of PKC-␥, -␦, and -was not changed by dopamine (Fig. 1) . Time course studies showed that an increase of PKC-␣ and -⑀ immunofluorescence signal in the region of the plasma membrane had already occurred within 20 s and was sustained for at least 15 min (Fig. 2) .
Translocation of PKC-⑀ was abolished by the D 1 receptor subtype antagonist Sch-23390 (10 Ϫ5 M, 10 min) but not by the D 2 receptor subtype antagonist S-sulpiride (10 Ϫ5 M, 10 min). Translocation was also abolished in cells preincubated with the PLC inhibitor U-73122 (5 ϫ 10 Ϫ6 M, 10 min) but not in cells incubated with the same concentration of the inactive analog U-73343 (Fig. 3) .
PKC translocation was also studied with subcellular fractionation and immunoblotting of the cytosolic and membrane fractions. It was found that, under resting conditions, PKC-␣ appeared mainly in the cytosol fraction, whereas PKC-⑀ was found mainly in the mem- brane fraction. Densitometric analysis of PKC-␣ in the cytosol and membrane fractions showed a significant increase in the ratio of membrane to cytosol signal after 10-min incubation with dopamine (10 Ϫ5 M). An even more pronounced increase was observed in fractions from cells incubated with phorbol ester (10 Ϫ6 M). Similar increases in the ratio of membrane to cytosol signal were found for PKC-⑀ (Fig. 4) .
The functional importance of the dopamine-PKC pathway in LLCPK cells is shown in Fig. 5 . Dopamine inhibition of the activity of Na ϩ -K ϩ -ATPase was measured as ouabain-dependent 86 Rb ϩ uptake and was completely abolished by the PKC inhibitor Ro-318220 in sodium-loaded cells (see METHODS for details). Previous results from our and other laboratories have demonstrated that, in rat renal epithelial cells, dopamine inhibits Na ϩ -K ϩ -ATPase through a PKC-mediated pathway (3, 7) . The serine residue 23 in the NH 2 -terminal of the catalytic ␣-subunit of rat Na ϩ -K ϩ -ATPase is a substrate for PKC phosphorylation (2, 8, 12) . So far there is no evidence for a PKC phosphorylation motif in the ␣-subunit of pig Na 
DISCUSSION
Intrarenal dopamine is a key modulator of sodium metabolism and blood pressure (9) . It is therefore of the utmost importance to understand the intracellular pathways by which dopamine can produce its physiological read out. Previous studies have provided circumstantial evidence that renal dopamine receptors may, in addition to their well-known effects on cAMP and protein kinase A, also activate PKC (10, 20, 21) . We now provide direct evidence that dopamine selectively activates the PKC ␣-and ⑀-isoforms in renal epithelial cells.
The effects of dopamine on PKC translocation were mediated via activation of the D 1 receptor subtype in LLCPK-1. We also found that dopamine-mediated PKC translocation was abolished in the presence of the PLC inhibitor U-73122. Together, these findings corrobo- (Ro; 10 Ϫ7 M, for 10 min; n ϭ 7), DA (10 Ϫ5 M, for 3 min; n ϭ 5), or a combination of both (Ro for 10 min and DA for 3 min; n ϭ 7). To clamp intracellular sodium concentration, all protocols that involved DA or Ro were performed in the presence of the sodium ionophore monensin (MO; 2 ϫ 10 Ϫ5 M, 20 min). Two control groups were used, one exposed to MO and one exposed to vehicle alone. In vehicle-incubated cells, ouabain-sensitive 86 
Rb
ϩ uptake was 31. The results from immunocytochemical and subcellular fractionation studies both demonstrated that dopamine can translocate PKC in renal cells. They did, however, differ in some aspects. The immunoblot studies indicated that, even in the absence of hormone stimulation, PKC-⑀ was predominantly found in the membrane fraction. This is in line with previous studies using subcellular fractionation (1, 11) . On the contrary, the confocal recordings indicated that PKC-⑀ was randomly located intracellularly under basal conditions. This discrepancy may be due to the fact that alterations in membrane-bound PKC-⑀ can occur during cell disruption and isolation of subcellular fractions (19) , a step that is avoided with the use of the confocal imaging technique.
By using confocal imaging, we could detect a dopamine-induced translocation of PKC-␣ and PKC-⑀ to the region of the plasma membrane within 20 s. It is generally assumed that activation of intracellular messengers occurs within seconds or fraction of seconds. In previous studies, performed with the use of subcellular fractionation, the effect of first messengers on PKC translocation was recorded after at least 10 min of incubation (5, 18) . Such a long delay may include a series of alternative biochemical events.
The effects of phorbol esters were more pronounced than the effects of dopamine in the subcellular fractionation studies. If dopamine-induced translocation is mediated by endogenous diacylglycerol, it will be more readily reversed than translocation mediated by exogenous phorbol esters. Thus, because of the rapid metabolism of phospholipids and diacylglycerol, hormoneinduced increases in PKC-membrane binding are more transient and less pronounced than the prolonged activation observed with phorbol ester treatment.
The PKC isoforms are subdivided into three families that are differently regulated and designated as classic, atypical, and novel PKCs. The classic PKCs are dependent on calcium for their activation, while the novel PKCs are independent of calcium. Both PKC subfamilies are activated by diacylglycerol (14) (15) (16) . In the present study we chose PKC-␣ and -␥ as representatives of the classic PKCs, PKC-␦ and -⑀ as representatives of the novel PKCs, and PKC-as a representative of the atypical PKCs. Dopamine was found to translocate both the classic ␣-and the novel ⑀-isoform. Interestingly, dopamine differentially regulated two members of the novel PKC family, namely, PKC-␦ and -⑀. The differential regulation of different PKC isoforms is an important topic, since there is a need for drugs that can selectively inhibit a certain isoform.
In conclusion, dopamine-induced translocation of PKC toward the plasma membrane will allow PKC to act on integral membrane protein. This is an attractive hypothetical model to explain dopamine-PKC-mediated regulation of ion pumps, channels, and other transporters in the plasma membrane of renal cells.
